ReviewThe International journal of angiology : official publication of the International College of Angiology, Inc2026
Diagnostic Imaging Pathways in Peripheral Artery Disease: A Comparative Review of Duplex Ultrasound Through Computed Tomography Angiography.
Review in The International journal of angiology : official publication of the International College of Angiology, Inc, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peripheral artery disease (PAD) is a major global health challenge, affecting more than 200 million people worldwide and an estimated 8 to 12 million in the United States. Its clinical spectrum ranges from intermittent claudication to chronic limb-threatening ischemia and acute limb ischemia. Accurate vascular imaging is essential for diagnosis, risk stratification, treatment planning, and postprocedural surveillance, guiding management from conservative therapy to endovascular or surgical revascularization. In this review, we aim to summarize the contemporary imaging pathways in PAD, focusing on noninvasive methods-duplex ultrasound (DUS), computed tomography angiography (CTA), and magnetic resonance angiography (MRA)-and invasive strategies such as digital subtraction angiography (DSA) with adjunct intravascular imaging. DUS, with high sensitivity for detecting ≥50% stenosis, is a cost-effective, radiation-free first-line modality, though operator dependence and acoustic shadowing may limit accuracy in heavily calcified vessels. CTA offers rapid, high-resolution anatomical assessment but requires ionizing radiation and iodinated contrast. MRA provides excellent soft-tissue contrast without radiation, with noncontrast techniques such as quiescent-interval single-shot (QISS) mitigating gadolinium-related concerns in renal dysfunction. As of now, DSA remains the gold standard, with intravascular modalities including intravascular ultrasound and optical coherence tomography improving lesion characterization and optimizing endovascular therapy. Angioscopy and near-infrared spectroscopy contribute additional structural or lipid-content insights. Emerging technologies-photon-counting computed tomography (CT), photoacoustic imaging, and artificial intelligence-augmented analysis-promise enhanced resolution, reduced artifact burden, and improved physiological and molecular assessment. Current American College of Cardiology/American Heart Association and ESC guidelines endorse DUS as the initial diagnostic test, with CTA or MRA selected according to renal function, calcification severity, and revascularization planning needs. Tailoring imaging strategies to patient-specific characteristics enables more precise intervention, reduces amputation risk, and advances personalized PAD care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.